Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Cogent Biosciences, Inc. (COGT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
9 Jun 2023
Fairmount Funds Management LLC
10% Owner, See Remarks
Cogent Biosciences, Inc.
(COGT)
3,272,124
+32%
800,000
$12.00
$9,600,000.00
BUY
12 Dec 2022
Christopher L. Jacobs
Congressman (House)
Cogent Biosciences, Inc.
(COGT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
16 Jun 2022
Fairmount Funds Management LLC
10% Owner, See Remarks
Cogent Biosciences, Inc.
(COGT)
2,472,124
+94%
1,200,000
$8.25
$9,900,000.00
SELL
26 Apr 2021
Green John L.
Chief Financial Officer, Officer
Cogent Biosciences, Inc.
(COGT)
3,841
-82%
17,813
$8.86
$157,823.17
BUY
14 Aug 2020
Venrock Healthcare Capital Partners III, L.P.
10% Owner
Unum Therapeutics Inc.
(UMRX)
4,355,273
+2%
112,750
$10.09
$1,137,120.00
SELL
6 Apr 2020
CAMPANA DARIO
10% Owner
Cogent Biosciences, Inc.
(COGT)
3,095,114
-13%
500,000
$1.58
$788,383.25
SELL
25 Mar 2019
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$16.49
$47,334.28
SELL
25 Feb 2019
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$17.01
$48,852.60
SELL
26 Dec 2018
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$16.19
$46,486.68
SELL
26 Nov 2018
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$28.02
$80,444.39
SELL
25 Oct 2018
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$33.85
$97,201.00
SELL
25 Sep 2018
Ettenberg Seth
Chief Scientific Officer, Officer
Unum Therapeutics Inc.
(UMRX)
0
-100%
2,871.25
$49.87
$143,181.19
BUY
3 Apr 2018
Ratcliffe Liam
Director
Unum Therapeutics Inc.
(UMRX)
897,772
+18%
137,500
$48.00
$6,600,000.00
BUY
3 Apr 2018
Atlas Venture Fund IX, L.P.
10% Owner
Unum Therapeutics Inc.
(UMRX)
3,361,535
+0%
23,513
$48.00
$1,128,624.00
BUY
3 Apr 2018
Booth Bruce
Director
Unum Therapeutics Inc.
(UMRX)
3,361,535
+0%
23,513
$48.00
$1,128,624.00
BUY
3 Apr 2018
FMR LLC
See Remark 1
Unum Therapeutics Inc.
(UMRX)
452,115
+5%
23,513
$48.00
$1,128,624.00
Home